In International journal of general medicine
Retinopathy of prematurity (ROP) is a vasoproliferative disorder with an imminent risk of blindness, in cases where early diagnosis and treatment are not performed. The doctors' constant motivation to give these fragile beings a chance at life with optimal visual acuity has never stopped, since Terry first described this condition. Thus, throughout time, several specific advancements have been made in the management of ROP. Apart from the most known risk factors, this narrative review brings to light the latest research about new potential risk factors, such as: proteinuria, insulin-like growth factor 1 (IGF-1) and blood transfusions. Digital imaging has revolutionized the management of retinal pathologies, and it is more and more used in identifying and staging ROP, particularly in the disadvantaged regions by the means of telescreening. Moreover, optical coherence tomography (OCT) and automated diagnostic tools based on deep learning offer new perspectives on the ROP diagnosis. The new therapeutical trend based on the use of anti-VEGF agents is increasingly used in the treatment of ROP patients, and recent research sustains the theory according to which these agents do not interfere with the neurodevelopment of premature babies.
Bujoreanu Bezman Laura, Tiutiuca Carmen, Totolici Geanina, Carneciu Nicoleta, Bujoreanu Florin Ciprian, Ciortea Diana Andreea, Niculet Elena, Fulga Ana, Alexandru Anamaria Madalina, Stan Daniela Jicman, Nechita Aurel
2023
anti-VEGF, artificial intelligence, optical coherence tomography, retinopathy of prematurity, risk factors, telescreening
